Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by regoselleron Oct 01, 2019 3:47pm
105 Views
Post# 30183750

My train of thought that is worth 0.02

My train of thought that is worth 0.02

I also want to put my two cents here.

Much frustration comes from self-doubting: APHA is really a solid
company in terms of fundamental, but this is in direct conflict to its SP.
Am I crazy? Is market correct and I'm wrong?

But then..

Using any metric there is out there (e.g. P/B) APHA is severely undervalued,
they are trading at book value, i.e. market says APHA has no future prospect.

Now, if you've done your DD, how much do you think APHA should be?

Using peer comparision as of today, even taking into account that APHA's
reputation is tainted by the short attack, it's SP should be above USD$8,
and that's being very conservative.

So now should be the opportunity to buy, because market is currently inefficient,
and failed to value APHA fairly.

This does NOT apply to companies such as CGC, ACB, CRON. Their P/B
ratios are still pretty high, and road to profitable is long.

APHA is only guilty by association.

When constellation happened, people who got in early, those who got in low
and held, were the one who were rewarded.  These were called investors.
Traders who got in and out, often missed out on the side line.

That's not to say you should never sell and hold. You can hold a core position
and trade a little. Develop your own strategy, do your due dilligence, be cautious.

GLTA
Bullboard Posts